PPA
INFI

Parametric Portfolio Associates’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Parametric Portfolio Associates’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-46,103
Closed -$104K – 3789
2021
Q4 		$104K Buy
46,103
+16,742
+57% +$42K ﹤0.01% 3546
2021
Q3 		$100K Buy
29,361
+19,127
+187% +$59K ﹤0.01% 3535
2021
Q2 		$31K Buy
+10,234
New +$32.4K ﹤0.01% 3552
2020
Q1 		– Sell
-10,463
Closed -$10K – 4032
2019
Q4 		$10K Buy
+10,463
New +$11.5K ﹤0.01% 3953
2019
Q3 		– Sell
-42,114
Closed -$76K – 4016
2019
Q2 		$76K Buy
+42,114
New +$67.8K ﹤0.01% 3869
2016
Q4 		– Sell
-19,355
Closed -$30K – 3812
2016
Q3 		$30K Buy
+19,355
New +$29.7K ﹤0.01% 3745
2015
Q4 		– Sell
-18,674
Closed -$158K – 3995
2015
Q3 		$158K Buy
18,674
+6,932
+59% +$63.9K ﹤0.01% 3130
2015
Q2 		$129K Sell
11,742
-10,537
-47% -$135K ﹤0.01% 3842
2015
Q1 		$311K Buy
22,279
+170
+0.8% +$2.6K ﹤0.01% 3542
2014
Q4 		$373K Buy
22,109
+4,279
+24% +$62.3K ﹤0.01% 3430
2014
Q3 		$239K Sell
17,830
-4,437
-20% -$52.8K ﹤0.01% 3555
2014
Q2 		$284K Buy
22,267
+8,381
+60% +$87.3K ﹤0.01% 3547
2014
Q1 		$165K Buy
+13,886
New +$186K ﹤0.01% 3669

Other funds holding INFI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Parametric Portfolio Associates's INFI Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2022, closing a stake of 46,103 shares — an estimated $104K sold.

Parametric Portfolio Associates first reported a position in INFI in Q1 2014 and held it in 13 quarters. The position peaked at $373K in Q4 2014. 93 funds tracked by Wall St. Rank hold INFI as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 46,103 Infinity Pharmaceuticals, Inc. shares in Q1 2022, an estimated $104K.
  • Parametric Portfolio Associates first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 13 quarters.
  • Parametric Portfolio Associates's Infinity Pharmaceuticals, Inc. position peaked at $373K in Q4 2014.
  • 93 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.